Metal-based antitumor compounds: beyond cisplatin

Despite improvements in the 5-year survival rate to over 80% in cancers, such as Hodgkin lymphoma and testicular cancer, more aggressive tumors including pancreatic and brain cancer still have extremely low survival rates. The establishment of chemoresistance, responsible for the reduction in treatm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Future medicinal chemistry 2019-01, Vol.11 (2), p.119-135
Hauptverfasser: Simpson, Peter V, Desai, Nima Maheshkumar, Casari, Ilaria, Massi, Massimiliano, Falasca, Marco
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!